Work

Organization of Pharmaceutical Care for Cardiac Rhythm Disorders

Year: 2025

Type: conference-paper

Abstract: This extensive study investigates antithrombotic therapy optimization for patients with cardiac rhythm disorders (CRDs), with a specific focus on atrial fibrillation (AF), supraventricular, and ventricular arrhythmias, frequently accompanied by ischemic heart disease. Conducted from 2020 to 2023 across various cardiology departments in Uzbekistan, the study evaluated 250 patients to examine their adherence to oral anticoagulant (OAC) therapy, the potential of platelet microvesicles (PMVs) as biomarkers for thromboembolic risk, and the alignment of clinical practices with international antithrombotic guidelines.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.15232160

Authors: Turayev Kh.N., Ziyadullayev Sh.X.

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6912103285

FWCI:

Cites:

Cited by:

Related to: